Institutional members access full text with Ovid®

Share this article on:

RISK FACTORS FOR CENTRAL SEROUS CHORIORETINOPATHY: A Systematic Review and Meta-Analysis

Liu, Bing MD*; Deng, Tuo MD; Zhang, Junjun MD*

doi: 10.1097/IAE.0000000000000837
Review

Purpose: Central serous chorioretinopathy (CSC) is a common retina disease and has a relative high recurrence rate, etiology, and pathogenesis of which remains ambiguous. The systematic review and meta-analysis aimed to measure risk factors for CSC in a quantitative method, providing some precautions and interventions on this disease and preventing further recurrences.

Methods: A comprehensive literature review relating to risk factors for CSC through PubMed, Embase, Cochrane Library, China National Knowledge Infrastructure (CNKI), and VIP databases was conducted before March 2015. Odds ratio (OR) with 95% confidence interval (CI) was calculated after data combination to assess the associations between risk factors and CSC.

Results: A total of 9839 patients in 17 studies were included and risk factors with significant differences found between CSC and control groups were listed as follows: hypertension (OR = 1.7; 95% CI: 1.28–2.25), Helicobacter pylori (H. pylori) infection (OR = 3.12; 95% CI: 1.81–5.40), steroid usage (OR = 4.29; 95% CI: 2.01–9.15), sleeping disturbance (OR = 1.90; 95% CI: 1.28–1.83), autoimmune disease (OR=3.44; 95% CI: 1.90–6.26), psychopharmacologic medication use (OR = 2.69; 95% CI: 1.63–4.45), and Type-A behavior (OR = 2.53; 95% CI: 1.08–5.96).

Conclusion: The authors concluded that hypertension, H. pylori infection, steroid usage, sleeping disturbance, autoimmune disease, psychopharmacologic medication use, and Type-A behavior were possible risk factors relating to the occurrence of CSC.

A systematic review and meta-analysis that aimed to analyze risk factors for central serous chorioretinopathy in a quantitative method based on combination statistics, providing some precautions and interventions on this disease and preventing further recurrences.

Departments of *Ophthalmology, and

Urology, West China Hospital, Sichuan University, Chengdu, China.

Reprint requests: Junjun Zhang, MD, Department of Ophthalmology, West China Hospital, Sichuan University, Chengdu 610041, China; e-mail: zhangjunjun@medmail.com.cn

B. L. and T. D. contributed equally to this work. None of the authors have any financial/conflicting interests to disclose.

© 2016 by Ophthalmic Communications Society, Inc.